1,3-Butadiene exposure and metabolism among Japanese American, Native Hawaiian, and white smokers

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 11, 2014, Pages 2240-2249

  Park, Sungshim Lani ^a   Kotapati, Srikanth ^b   Wilkens, Lynne R ^c   Tiirikainen, Maarit ^c   Murphy, Sharon E ^b   Tretyakova, Natalia ^b   Le Marchand, Loïc ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; ACETYLCYSTEINE DERIVATIVE; CREATININE; DIHYDROXYBUTYL MERCAPTURIC ACID; MONOHYDROXYBUTYL MERCAPTURIC ACID; NICOTINE; TUMOR MARKER; UNCLASSIFIED DRUG; 1,2-DIHYDROXYBUTYL MERCAPTURIC ACID; 1,3 BUTADIENE DERIVATIVE; 1,3-BUTADIENE; 1-HYDROXYBUTENE-2-YL MERCAPTURIC ACID; ACETYLCYSTEINE; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE;

AGE; ARTICLE; ASIAN AMERICAN; BODY MASS; CANCER PATIENT; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; COPY NUMBER VARIATION; CREATININE BLOOD LEVEL; ENVIRONMENTAL EXPOSURE; ETHNIC DIFFERENCE; FEMALE; GENOTYPE; GEOMETRY; GSTT1 GENE; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METABOLISM; NATIVE HAWAIIAN; NORMAL VALUE; RACE DIFFERENCE; SEX RATIO; SMOKING; TUMOR GENE; UNITED STATES; URINALYSIS; URINARY EXCRETION; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; ETHNOLOGY; GENETICS; JAPAN; LUNG NEOPLASMS; OCEANIC ANCESTRY GROUP; SEX DIFFERENCE; URINE;

ACETYLCYSTEINE; ASIAN AMERICANS; BUTADIENES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HAWAII; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; OCEANIC ANCESTRY GROUP; SEX FACTORS; SMOKING;

EID: 84920199157     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0492     Document Type: Article

References (46)

1. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008:GLOBOCAN2008. Int J Cancer 2010;127:2893-917.
2. Le Marchand L, Wilkens LR, Kolonel LN. Ethnic differences in the lung cancer risk associated with smoking. Cancer Epidemiol Biomarkers Prev. 1992;1:103-7.
3. Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med 2006;354:333-42.
4. University of Hawaii Cancer Center. In:Green M, editor. Hawaii cancer facts and figures 2010. Honolulu, HI: University of Hawaii Cancer Center; 2010.
5. Derby KS, Cuthrell K, Caberto C, Carmella SG, Franke AA, Hecht SS, et al. Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer. Cancer Epidemiol Biomarkers & Prev 2008;17: 3526-35.
6. Himmelstein MW, Acquavella JF, Recio L, Medinsky MA, Bond JA. Toxicology and epidemiology of 1,3-butadiene. Crit Rev Toxicol 1997;27:1-108.
7. Brunnemann KD, Kagan MR, Cox JE, Hoffmann D. Analysis of 1,3-butadiene and other selected gas-phase components in cigarette mainstream and sidestream smoke by gas chroma-tography-mass selective detection. Carcinogenesis 1990;11: 1863-8.
8. Melnick RL, Huff J, Chou BJ, Miller RA. Carcinogenicity of 1,3-butadiene in C57BL/6 x C3H F1 mice at low exposure concentrations. Cancer Res 1990;50:6592-9.
9. Huff JE, Melnick RL, Solleveld HA, Haseman JK, Powers M, Miller RA. Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science 1985;227: 548-9.
10. National Toxicology P. NTP toxicology and carcinogenesis studies of 1,3-butadiene (CAS No. 106-99-0) in B6C3F1 mice (Inhalation studies). Natl Toxicol Program Tech Rep Ser 1984;288:1-111.
11. Owen PE, Glaister JR, Gaunt IF, Pullinger DH. Inhalation toxicity studies with 1,3-butadiene. 3. Two year toxicity/carcinogenicity study in rats. Am Ind Hyg Assoc J 1987;48:407-13.
12. Fowles J, Dybing E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob Control 2003;12:424-30.
13. International Agency for Research on Cancer. 1,3-Butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide). Lyon, France: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans; 2008. Volume 97.
14. Roethig HJ, Munjal S, Feng S, Liang Q, Sarkar M, Walk R-A, et al. Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers. Nicotine Tob Res 2009; 11:1216-25.
15. Yuan J-M, Gao Y-T, Wang R, Chen M, Carmella SG, Hecht SS. Urinary levels of volatile organic carcinogen and toxicant biomarkers in relation to lung cancer development in smokers. Carcinogenesis 2012;33: 804-9.
16. Cheng H, Sathiakumar N, Graff J, Matthews R, Delzell E. 1,3-Butadiene and leukemia among synthetic rubber industry workers: exposure-response relationships. Chem Biol Interact 2007;166:15-24.
17. Duescher RJ, Elfarra AA. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1. Arch Biochem Biophys 1994;311: 342-9.
18. Fustinoni S, Soleo L, Warholm M, Begemann P, Rannug A, Neumann HG, et al. Influence of metabolic genotypes on biomarkers of exposure to 1,3-butadiene in humans. Cancer Epidemiol Biomarkers Prev 2002;11:1082-90.
19. Wiencke JK, Pemble S, Ketterer B, Kelsey KT. Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev 1995;4:253-9.
20. Gsur A, Zidek T, Schnattinger K, Feik E, Haidinger G, Hollaus P, et al. Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk. Br J Cancer 2003;89:702-6.
21. Yoshikawa M, Hiyama K, Ishioka S, Maeda H, Maeda A, Yamakido M. Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese. Int J Mol Med 2000; 5:49-53.
22. London SJ, Smart J, Daly AK. Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County. Lung Cancer 2000;28:147-55.
23. Nakajima M, Fukami T, Yamanaka H, Higashi E, Sakai H, Yoshida R, et al. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. Clin Pharmacol Ther 2006;80:282-97.
24. Borgie M, Garat A, Cazier F, Delbende A, Allorge D, Ledoux F, et al. Traf fic-related air pollution. A pilot exposure assessment in Beirut, Lebanon. Chemosphere 2014;96:122-8.
25. Cheng X, Zhang T, Zhao J, Zhou J, Shao H, Zhou Z, et al. The association between genetic damage in peripheral blood lymphocytes and polymorphisms of three glutathione S-transferases in Chinese workers exposed to 1,3-butadiene. Mutat Res/Genet Toxicol Environ Mutagenesis 2013;750:139-46.
26. Derby KS, Cuthrell K, Caberto C, Carmella S, Murphy SE, Hecht SS, et al. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer. Int J Cancer 2009;125: 2418-24.
27. Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, Pike MC, et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 2000;151:346-57.
28. Hecht SS, Carmella SG, Chen M, Koch D, Miller AT, Murphy SE, et al. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res 1999;59: 590-6.
29. Hecht SS, Carmella SG, Murphy SE. Effects of watercress consumption on urinary metabolites of nicotine in smokers. Cancer Epidemiol Biomarkers Prev 1999;8:907-13.
30. Tricker AR. Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour. Toxicology 2003;183: 151-73.
31. Malaiyandi V, Goodz SD, Sellers EM, Tyndale RF. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking. Cancer Epidemiol Biomarkers Prev 2006;15: 1812-9.
32. Urban M, Gilch G, Schepers G, van Miert E, Scherer G. Determination of the major mercapturic acids of 1,3-butadiene in human and rat urine using liquid chromatography with tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2003;796: 131-40.
33. Parl FF. Glutathione S-transferase genotypes and cancer risk. Cancer Lett 2005;221:123-9.
34. Csanady GA, Guengerich FP, Bond JA. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis 1992;13:1143-53.
35. Duescher RJ, Elfarra AA. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1. Arch Biochem Biophys 1994;311: 342-9.
36. Krause RJ, Sharer JE, Elfarra AA. Epoxide hydrolase-dependent metabolism of butadiene monoxide to 3-butene-1,2-diol in mouse, rat, and human liver. Drug Metab Dispos 1997;25:1013-5.
37. Sprague CL, Elfarra AA. Mercapturic acid urinary metabolites of 3-butene-1,2-diol as in vivo evidence for the formation of hydroxymethylvinyl ketone in mice and rats. Chem Res Toxicol 2004;17: 819-26.
38. van Sittert NJ, Megens HJ, Watson WP, Boogaard PJ. Biomarkers of exposure to 1,3-butadiene as a basis for cancer risk assessment. Toxicol Sci 2000;56:189-202.
39. Swenberg JA, Bordeerat NK, Boysen G, Carro S, Georgieva NI, Nakamura J, et al. 1,3-Butadiene: biomarkers and application to risk assessment. Chem Biol Interact 2011;192:150-4.
40. Boogaard PJ, van Sittert NJ, Megens HJ. Urinary metabolites and haemoglobin adducts as biomarkers of exposure to 1,3-butadiene: a basis for 1,3-butadiene cancer risk assessment. Chem Biol Interact 2001;135-136:695-701.
41. Albertini RJ, Sram RJ, Vacek PM, Lynch J, Rossner P, Nicklas JA, et al. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons. Chem Biol Interact 2007;166: 63-77.
42. Sapkota A, Halden RU, Dominici F, Groopman JD, Buckley TJ. Urinary biomarkers of 1,3-butadiene in environmental settings using liquid chromatography isotope dilution tandem mass spectrometry. Chem Biol Interact 2006;160:70-9.
43. Albertini RJ, Sram RJ, Vacek PM, Lynch J, Wright M, Nicklas JA, et al. Biomarkers for assessing occupational exposures to 1,3-butadiene. Chem Biol Interact 2001;135-136:429-53.
44. Carmella SG, Chen M, Han S, Briggs A, Jensen J, Hatsukami DK, et al. Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem Res Toxicol 2009;22: 734-41.
45. McKee SA, Falba T, O'Malley SS, Sindelar J, O'Connor PG. Smoking status as a clinical indicator for alcohol misuse in US adults. Arch Int Med 2007;167:716-21.
46. Benowitz NL, Dains KM, Dempsey D, Wilson M, Jacob P. Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure. Nicotine Tob Res 2011;13: 772-83.